Alaunos Therapeutics (TCRT) Restructuring Costs (2023)
Alaunos Therapeutics (TCRT) reported Restructuring Costs of $850000.0 for Q4 2023, up 102.86% quarter-over-quarter from $419000.0 in Q3 2023.
Alaunos Therapeutics (TCRT) Restructuring Costs (2023) Analysis & Trends
Alaunos Therapeutics has reported Restructuring Costs for 1 years, with the latest figure at $850000.0 in Q4 2023.
- For the quarter ending Q4 2023, Restructuring Costs changed N/A year-over-year to $850000.0; the trailing twelve-month figure through Dec 2024 stood at $1.3 million (changed 0.0% YoY), and the FY2023 full-year result was $1.3 million, changed N/A from the prior year.
- Restructuring Costs for Q4 2023 stood at $850000.0, up from $419000.0 in the prior quarter.
- The five-year high for Restructuring Costs was $850000.0 in Q4 2023, with the low at $419000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Alaunos Therapeutics | 4.31 Mn | 3.95 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 850,000.00 |
| Sep 30, 2023 | 419,000.00 |